Employees Retirement System of Texas’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,432
Closed -$79K 512
2025
Q3
$79K Hold
5,432
﹤0.01% 417
2025
Q2
$61K Hold
5,432
﹤0.01% 467
2025
Q1
$31K Hold
5,432
﹤0.01% 264
2024
Q4
$53K Hold
5,432
﹤0.01% 308
2024
Q3
$44K Hold
5,432
﹤0.01% 332
2024
Q2
$73K Hold
5,432
﹤0.01% 307
2024
Q1
$252K Buy
5,432
+2,675
+97% +$138K ﹤0.01% 307
2023
Q4
$186K Buy
+2,757
New +$169K ﹤0.01% 324

Other funds holding DNA

Employees Retirement System of Texas's DNA Position: Q4 2025 in Review

Employees Retirement System of Texas sold out of Ginkgo Bioworks (DNA) in Q4 2025, closing a stake of 5,432 shares — an estimated $79K sold.

Employees Retirement System of Texas first reported a position in DNA in Q4 2023 and held it in 8 quarters. The position peaked at $252K in Q1 2024. 180 funds tracked by Wall St. Rank hold DNA as of Q4 2025.

  • Employees Retirement System of Texas reported no remaining Ginkgo Bioworks position as of Q4 2025 after selling out during the quarter.
  • Employees Retirement System of Texas sold 5,432 Ginkgo Bioworks shares in Q4 2025, an estimated $79K.
  • Employees Retirement System of Texas first reported a position in Ginkgo Bioworks in Q4 2023 and held it in 8 quarters.
  • Employees Retirement System of Texas's Ginkgo Bioworks position peaked at $252K in Q1 2024.
  • 180 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2025.

Based on Employees Retirement System of Texas's 13F filing for Q4 2025, filed 9 Feb 2026.